article thumbnail

Bayer sells testosterone drug rights to Grünenthal for €500m

pharmaphorum

The legacy product now lies outside Bayer’s core areas of cardiology, oncology, haematology, ophthalmology, women’s health and radiopharmaceuticals, and the funds raised from the sale will support the “ongoing transformation of Bayer’s pharma business to focus on key areas of future medical innovation”, said the company.

Drugs 97
article thumbnail

Boehringer-backed digital health academy set for launch in UK

pharmaphorum

The Digital Health Academy – developed with pharma company Boehringer Ingelheim – is part of a drive to get digital health tools and apps used more routinely in the management of health conditions, according to ORCHA.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digital Innovators: Wellthy Therapeutics’ Abhishek Shah

pharmaphorum

Wellthy developed partnerships with pharma companies across Europe & Asia, which Abhishek says is helping his company address unmet patient needs through digital health solutions. He provides insights into pharma companies’ structural changes and tips on telltale signs of good pharma partners.

article thumbnail

Huma’s Kaushik Gune on SaMD and the Company’s Partnership with Bayer

XTalks

We did not get a Class II certification for diabetes only, or orthopedics or cardiology; we got a disease-agnostic certification. Now, as we develop new predictive algorithms, whether that is in diabetes, cardiology, respiratory or oncology, we can bring those algorithms to our platform because it is disease-agnostic.

article thumbnail

Disrupted medical conferences: Lessons learnt

pharmaphorum

Major societies such as the European Society of cardiology (ESC) reported a 177% increase in attendees for its 2020 annual congress : 77,350 virtual attendees (logged-on) 2020 cf 27,946 physical attendees 2019. One important caveat here is that delegate registration fees were waived. About the author.

Doctors 105
article thumbnail

A history of Johnson & Johnson

pharmaphorum

By most measures the single largest pharma company in the world, US-based Johnson & Johnson (J&J) is also arguably one of the most well-known drugmakers among the general public. . This move revolutionised cardiology – coronary stents keep vessels open so blood can flow to the heart.

Sales 126
article thumbnail

Combo ‘Polypill’ May Cut Heart Attack, Stroke Risk Up to 40%

The Pharma Data

. “When you look at the combination of aspirin and the polypill, you definitely see a meaningful reduction in cardiovascular events,” said Dr. Eugene Yang, chair-elect of the American College of Cardiology’s Prevention of Cardiovascular Disease Council.

Doctors 52